Ranking by Regions
United States
Canada
Mexico
Brazil
Chile
Germany
United Kingdom
France
Spain
Netherlands
Sweden
Italy
Switzerland
Poland
Finland
China
Japan
South Korea
Hong Kong
Singapore
Indonesia
India
Malaysia
Taiwan
Thailand
Australia
New Zealand
Israel
Saudi Arabia
Turkey
Russia
South AfricaRanking by categories
As of January 22, 2025, Stoke Therapeutics (STOK) has a market cap of $0.53 billion USD. According to our data, Stoke Therapeutics is ranked No.6042 in global market value.
| Year | Market Cap | %Change |
|---|---|---|
| Jan 22, 2025 | $0.53 B |
-9.16%
|
| Dec 31, 2024 | $0.58 B |
109.70%
|
| Dec 29, 2023 | $0.28 B |
-43.01%
|
| Dec 30, 2022 | $0.49 B |
-61.53%
|
| Dec 31, 2021 | $1.27 B |
-61.26%
|
| Dec 31, 2020 | $3.28 B |
118.68%
|
| Dec 31, 2019 | $1.50 B |
100%
|
| Name | Market Cap | Market cap difference | Regions |
|---|---|---|---|
 Ionis Pharmaceuticals
IONS
|
$5.13 B |
-0.000 M
|
USA
|
 Wave Life Sciences
WVE
|
$1.78 B |
0.000 M
|
Singapore
|
 Alnylam Pharmaceuticals
ALNY
|
$34.38 B |
-0.000 M
|
USA
|
 Sarepta Therapeutics
SRPT
|
$11.09 B |
0.000 M
|
USA
|
 Moderna
MRNA
|
$14.82 B |
-0.000 M
|
USA
|
 Biogen
BIIB
|
$20.80 B |
0.000 M
|
USA
|
 Regeneron Pharmaceuticals
REGN
|
$74.73 B |
1.236 B
|
USA
|
 Vertex Pharmaceuticals
VRTX
|
$110.22 B |
0.001 M
|
USA
|
 Exelixis
EXEL
|
$9.39 B |
0.000 M
|
USA
|
 Amgen
AMGN
|
$146.98 B |
0.004 M
|
USA
|
 Rocket Pharmaceuticals
RCKT
|
$1.11 B |
-0.000 M
|
USA
|
 Arcturus Therapeutics
ARCT
|
$0.45 B |
0.000 M
|
USA
|
 CRISPR Therapeutics
CRSP
|
$3.77 B |
-0.000 M
|
Switzerland
|
 Editas Medicine
EDIT
|
$0.11 B |
-0.000 M
|
USA
|
 bluebird bio
BLUE
|
$76.22 M |
0.000 M
|
USA
|
| Market Cap | = | STOK Stock Price | * | STOK Shares Outstanding |
| = | $10.02 | * | 52.97 M | |
| = | $0.53 B |